Caprock Group, LLC PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in Caprock Group, LLC  ·  5 quarters on record

AI Ownership Summary

Caprock Group, LLC reported PUMA BIOTECHNOLOGY INC (PBYI) in 5 quarterly 13F filings from 2025 Q1 through 2026 Q2. The latest visible filing shows PBYI at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this PBYI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Caprock Group, LLC's position in PUMA BIOTECHNOLOGY INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

PBYI was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

PBYI stock page Caprock Group, LLC fund profile Caprock Group, LLC full holdings
How Caprock Group, LLC held PBYI — position size vs. price
% of Fund (quarterly)    PBYI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED — — — 13,862 -12,127 -46.7% 0.00% $112K 2026-07-27 $7.99
2026 Q1 ADDED — — — 25,989 +9,541 +58.0% 0.00% $166K 2026-05-11 $7.14
2025 Q4 ADDED — — — 16,448 +4,680 +39.8% 0.00% $98K 2026-01-28 $6.32
2025 Q3 REDUCED 14.8% +14.7% ❌ 11,768 -2,049 -14.8% 0.00% $59K 2025-11-06 $4.90
2025 Q1 INITIATED — — — 13,817 — — 0.00% $41K 2025-05-15 $3.28

🏢 Other funds also holding PBYI

As of 2026 Q2 — sorted by position size

Haven Private, LLC 0.46% C2C Wealth Management, LLC 3Y 0.15% PERKINS CAPITAL MANAGEMENT INC 3Y 7Y 0.08% Baron Wealth Management LLC 3Y 0.08% Williams & Novak, LLC 0.06% D'Orazio & Associates, Inc. 3Y 7Y 0.05% Prospera Financial Services Inc 3Y 7Y 0.02% Abel Hall, LLC 0.02% Kathmere Capital Management, LLC 3Y 0.01% EVERGREEN CAPITAL MANAGEMENT LLC 3Y 7Y 0.01%

FAQ About Caprock Group, LLC and PBYI

These are the practical questions this page is built to answer before you even open the full history table.

How long has Caprock Group, LLC reported owning PBYI?

Caprock Group, LLC reported PBYI across 5 quarterly 13F filings, from 2025 Q1 through 2026 Q2.

What was the largest reported PBYI position in Caprock Group, LLC's portfolio?

The largest reported portfolio weight for PBYI was 0.00% in 2026 Q1.

What is the latest reported PBYI position on this page?

The most recent filing on this page is 2026 Q2, when Caprock Group, LLC reported 13,862 shares, equal to 0.00% of portfolio, with an estimated market value of $112K.

What does the chart on this PBYI ownership page compare?

The chart compares Caprock Group, LLC's quarterly PBYI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Caprock Group, LLC time their PBYI position?

Based on 13F filing dates vs. subsequent PBYI price moves, Caprock Group, LLC correctly timed 3 out of 4 reported position changes (75%). The annualised alpha on PBYI relative to SPY over the holding period was +72.2%.

← Back to Caprock Group, LLC Holdings